

Pathway Therapeutics develops selective inhibitors of PI3-kinase and mTOR for the treatment of cancer and inflammatory diseases.
| Headquarter | 409 Illinois Street San Francisco, CA United States of America |
|---|---|
| Website | pathwaytx.com |
| Founding Date | 2008 |
| Company Status | Private |
1 employee at Pathway Therapeutics has reviewed Pathway Therapeutics across various culture dimensions, providing their opinions on items ranging from executive ratings to the pace at work. The latest review was months ago.

The prevailing opinion from Comparably users in San Francisco about their company is that it was very prepared on their first day. San Francisco employees concluded that their overall onboarding experience was positive. 78% said their direct manager was helpful with their acclimation during the first 90 days. First impressions are important, and how prepared a company is on your first day leaves a lasting impression.
At this moment no Pathway Therapeutics employees have provided insight into whether or not they clearly understand Pathway Therapeutics' KPIs and OKRs.

No Recent Jobs found for Pathway Therapeutics on Comparably
Mark that you are interested and we will alert you when there are new positions available listed on Comparably

Candidates By Department
IT | 50% | |
|---|---|---|
Engineering | 50% |
Candidates By Location
Seattle | 50% | |
|---|---|---|
Bonney Lake | 50% |
What is Pathway Therapeutics address?
Pathway Therapeutics location is at 409 Illinois Street
Who is the CEO of Pathway Therapeutics?
Pathway Therapeutics CEO is Julie Cherrington, their score by employees is 70
What is Pathway Therapeutics eNPS?
The eNPS for Pathway Therapeutics is 100
Who is Pathway Therapeutics leadership?
are part of Pathway Therapeutics leadership, Julie Cherrington is the CEO